ByHealth, China’s leading supplement brand, launches collagen joint health product featuring Bioiberica ingredient

ByHealth's new Highflex type II collagen tablets. Photo from Bioiberica.

ByHealth, China’s leading vitamin and dietary supplements company, has launched a new collagen product its Highflex joint health brand. The product features native (undenatured) type II collagen branded ingredient Collavant n2, from Bioiberica (Barcelona), which has been clinically shown to improve knee discomfort and function¹.

The new Highflex type II collagen tablets “are the first product to result from the companies’ strategic partnership, and boosts ByHealth’s well-established Highflex offering, which saw a 29.25% revenue increase in the first half of 2021 and is already the leading joint health brand in China,” the companies’ press release reports. The product offers effective joint support in a low dose, it adds.

In the press release, Jaume Reguant, healthcare director at Bioiberica, noted that while collagen’s skin health benefits are well known in China, there is room to grow awareness of its joint health benefits. “China is a particularly interesting and dynamic territory in the global mobility market. It has a large aging population and an emerging health-conscious younger generation, but collagen for joint health and mobility is a relatively new concept. There is therefore significant opportunity for brands looking to target Chinese consumers—especially if they educate them about the benefits of collagen beyond skin and beauty.”

Reference

1. Bakilan F et al. “Effects of native type II collagen treatment on knee osteoarthritis: A randomized controlled trial.” The European Journal of Medicine, vol. 48, no. 2 (June 2016): 95-101